The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-chloro-2-(3-(4-chlorophenylsulfonamido)quinoxalin-2-ylamino)benzoic acid ID: ALA2299388
PubChem CID: 1871291
Max Phase: Preclinical
Molecular Formula: C21H14Cl2N4O4S
Molecular Weight: 489.34
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)c1ccc(Cl)cc1Nc1nc2ccccc2nc1NS(=O)(=O)c1ccc(Cl)cc1
Standard InChI: InChI=1S/C21H14Cl2N4O4S/c22-12-5-8-14(9-6-12)32(30,31)27-20-19(24-16-3-1-2-4-17(16)25-20)26-18-11-13(23)7-10-15(18)21(28)29/h1-11H,(H,24,26)(H,25,27)(H,28,29)
Standard InChI Key: KDRUERVLJQMQQW-UHFFFAOYSA-N
Molfile:
RDKit 2D
32 35 0 0 0 0 0 0 0 0999 V2000
19.9042 -5.0352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9031 -5.8588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6152 -6.2719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3290 -5.8584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3262 -5.0316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6134 -4.6263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0374 -6.2700 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
19.1896 -4.6282 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1894 -3.8069 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.4778 -5.0370 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.6110 -3.8050 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.3216 -3.3902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0284 -3.8032 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.0185 -2.1605 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.3155 -2.5729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7366 -2.5668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7385 -3.3866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4488 -3.7952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1578 -3.3809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1519 -2.5580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4410 -2.1573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6007 -2.1694 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.5948 -1.3481 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
19.8800 -0.9405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8761 -0.1217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1622 0.2878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4523 -0.1320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4609 -0.9575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1754 -1.3614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7370 0.2743 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
21.3832 -1.5560 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.1686 -0.7594 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
8 9 1 0
8 10 2 0
1 8 1 0
6 11 1 0
11 12 1 0
12 13 2 0
13 17 1 0
16 14 1 0
14 15 2 0
15 12 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 16 2 0
15 22 1 0
22 23 1 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 24 1 0
27 30 1 0
23 31 2 0
23 32 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 489.34Molecular Weight (Monoisotopic): 488.0113AlogP: 5.18#Rotatable Bonds: 6Polar Surface Area: 121.28Molecular Species: ACIDHBA: 6HBD: 3#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: 3.60CX Basic pKa: ┄CX LogP: 6.58CX LogD: 2.42Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.34Np Likeness Score: -1.34
References 1. Park H, Kyung A, Lee H, Kang S, Yoon T, Ryu SE, Jeong DG. (2013) Virtual screening and biochemical evaluation of the inhibitors of dual-specificity phosphatase 26, 22 (8): [10.1007/s00044-012-0405-3 ]